GEMPHIRE THERAPEUTICS INC - COM (GEMP)

CUSIP: 36870A108

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
4,861,198
Share change
+1,555,635
Total reported value
$31,598,000
Price per share
$6.51
Number of holders
28
Value change
+$9,654,533
Number of buys
17
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 36870A108?
CUSIP 36870A108 identifies GEMP - GEMPHIRE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GEMPHIRE THERAPEUTICS INC - COM (GEMP) as of Q1 2018

As of 31 Mar 2018, GEMPHIRE THERAPEUTICS INC - COM (GEMP) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,861,198 shares. The largest 10 holders included Cormorant Asset Management, LP, NORTHPOINTE CAPITAL LLC, Exchange Capital Management, Inc., BAMCO INC /NY/, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, Stonepine Capital Management, LLC, Cambridge Investment Research Advisors, Inc., HIGHLAND CAPITAL MANAGEMENT LP, and DAFNA Capital Management LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.